Cargando…

Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study

Virus-like particles (VLPs) have emerged as a powerful scaffold for antigen presentation and delivery strategies. Compared to single protein-based therapeutics, quality assessment requires a higher degree of refinement due to the structure of VLPs and their similar properties to extracellular vesicl...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Domínguez, Irene, Puente-Massaguer, Eduard, Cervera, Laura, Gòdia, Francesc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077327/ https://www.ncbi.nlm.nih.gov/pubmed/32079288 http://dx.doi.org/10.3390/v12020223

Ejemplares similares

Transduction of HEK293 Cells with BacMam Baculovirus Is an Efficient System for the Production of HIV-1 Virus-like Particles
por: Puente-Massaguer, Eduard, et al.
Publicado: (2022)

Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells
por: Puente-Massaguer, Eduard, et al.
Publicado: (2020)

Characterization and quantitation of fluorescent Gag virus-like particles
por: Gutiérrez-Granados, Sonia, et al.
Publicado: (2013)

At‐line multi‐angle light scattering detector for faster process development in enveloped virus‐like particle purification
por: Pereira Aguilar, Patricia, et al.
Publicado: (2019)

An Alternative Perfusion Approach for the Intensification of Virus-Like Particle Production in HEK293 Cultures
por: Lavado-García, Jesús, et al.
Publicado: (2020)

Corrigendum: An Alternative Perfusion Approach for the Intensification of Virus-Like Particle Production in HEK293 Cultures
por: Lavado-García, Jesús, et al.
Publicado: (2021)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Gag Virus-like Particles Functionalized with SARS-CoV-2 Variants: Generation, Characterization and Recognition by COVID-19 Convalescent Patients’ Sera
por: Boix-Besora, Arnau, et al.
Publicado: (2023)

Differential N‐ and O‐glycosylation signatures of HIV‐1 Gag virus‐like particles and coproduced extracellular vesicles
por: Lavado‐García, Jesús, et al.
Publicado: (2022)

A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles
por: González-Domínguez, Irene, et al.
Publicado: (2021)

Optimization, Production, Purification and Characterization of HIV-1 GAG-Based Virus-like Particles Functionalized with SARS-CoV-2
por: Boix-Besora, Arnau, et al.
Publicado: (2022)

PEI-Mediated Transient Transfection of High Five Cells at Bioreactor Scale for HIV-1 VLP Production
por: Puente-Massaguer, Eduard, et al.
Publicado: (2020)

Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products
por: Mirabel, Clémentine, et al.
Publicado: (2018)

Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus
por: Fontana, Diego, et al.
Publicado: (2021)

Virus-Like Particles-Based Mucosal Nanovaccines
por: Rosales-Mendoza, Sergio, et al.
Publicado: (2019)

Optimization of HEK 293 cell growth by addition of non-animal derived components using design of experiments
por: Cervera, Laura, et al.
Publicado: (2011)

Quality assessment of virus-like particle: A new transmission electron microscopy approach
por: De Sá Magalhães, Salomé, et al.
Publicado: (2022)

Size-selective downstream processing of virus particles and non-enveloped virus-like particles
por: Hillebrandt, Nils, et al.
Publicado: (2023)

Characterization of Chikungunya Virus-Like Particles
por: Noranate, Nitchakarn, et al.
Publicado: (2014)

VIRUS-LIKE PARTICLES IN CALVES' FÆCES
por: Mcnulty, M.S., et al.
Publicado: (1975)

Virus-Like Particle and Nanoparticle Vaccines
por: Kanekiyo, M., et al.
Publicado: (2017)

VIRUS-LIKE PARTICLES IN INFECTIOUS HEPATITIS
por: Sirtori, Carlo
Publicado: (1970)

Thermal remodelling of Alternanthera mosaic virus virions and virus-like particles into protein spherical particles
por: Manukhova, Tatiana I., et al.
Publicado: (2021)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

Viruses and Virus-Like Particles in Biotechnology: Fundamentals and Applications
por: Roldão, A., et al.
Publicado: (2011)

Viruses and Virus-Like Particles in Biotechnology: Fundamentals and Applications
por: Roldão, A., et al.
Publicado: (2017)

Assessment of in vitro particle dosimetry models at the single cell and particle level by scanning electron microscopy
por: Kowoll, Thomas, et al.
Publicado: (2018)

Shifts of the spherical single particle levels
por: Sørensen, R A
Publicado: (1981)

Vaccine Potential of Nipah Virus-Like Particles
por: Walpita, Pramila, et al.
Publicado: (2011)

Programmable polymorphism of a virus-like particle
por: Biela, Artur P., et al.
Publicado: (2022)

PLEOMORPHIC VIRUS-LIKE PARTICLES IN HUMAN FÆCES
por: Mathan, M., et al.
Publicado: (1975)

Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020)

Shedding of “virus-like” particles in canine faeces
por: Hamilton, R.C., et al.
Publicado: (1995)

Virus-like Particle Vaccines for Norovirus Gastroenteritis
por: Chen, Qiang
Publicado: (2013)

Virus-like particles—universal molecular toolboxes
por: Ludwig, Christine, et al.
Publicado: (2007)

Virus-like particles: Passport to immune recognition
por: Grgacic, Elizabeth V.L., et al.
Publicado: (2006)

Virus-Like Particles as an Instrument of Vaccine Production
por: Syomin, B. V., et al.
Publicado: (2019)

Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Recent Progress on the Versatility of Virus-Like Particles
por: Qian, Ciying, et al.
Publicado: (2020)

In Vitro Assembly of Virus-Like Particles and Their Applications
por: Le, Dinh To, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ev9i2cpaumnrji4uqkb7e17a5i